99mTc-ZHER2:41071

N/A

Report date: 2025/12/23 20:00:10

NME

Base Information

Drug Name99mTc-ZHER2:41071

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A